Cargando…
Modulation of Stem Cells as Therapeutics for Severe Mental Disorders and Cognitive Impairments
Severe mental illnesses (SMI) such as schizophrenia and bipolar disorder affect 2-4% of the world population. Current medications and diagnostic methods for mental illnesses are not satisfying. In animal studies, stem cell therapy is promising for some neuropsychiatric disorders and cognitive/social...
Autores principales: | Zhang, Yongbo, Zhao, Yingying, Song, Xiaopeng, Luo, Hua, Sun, Jinmei, Han, Chunyu, Gu, Xiaohuan, Li, Jun, Cai, Guilan, Zhu, Yanbing, Liu, Zhandong, Wei, Ling, Wei, Zheng Zachory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205035/ https://www.ncbi.nlm.nih.gov/pubmed/32425815 http://dx.doi.org/10.3389/fpsyt.2020.00080 |
Ejemplares similares
-
Glial Cell-Based Vascular Mechanisms and Transplantation Therapies in Brain Vessel and Neurodegenerative Diseases
por: Zhao, Yingying, et al.
Publicado: (2021) -
Mental Disorders, Cognitive Impairment and the Risk of Suicide in Older Adults
por: Kułak-Bejda, Agnieszka, et al.
Publicado: (2021) -
The Effect of Cerebral Small Vessel Disease on the Subtypes of Mild Cognitive Impairment
por: Li, Xudong, et al.
Publicado: (2021) -
Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018) -
Editorial: Mental health in older adults with cognitive impairments and dementia: a multidisciplinary perspective
por: Jiang, Dongdong, et al.
Publicado: (2023)